Log in

Pro: Levosimendan bei herzchirurgischen Eingriffen

Pro: Levosimendan in Cardiac Surgery

  • Klinische Pharmakologie
  • Published:
Die Anaesthesiologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Spain)

Instant access to the full article PDF.

Literatur

  1. Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, Calabro MG, Grigoryev EV et al (2017) Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med 376:2021–2031

    Article  CAS  PubMed  Google Scholar 

  2. Mehta RH, Leimberger JD, Van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D et al (2017) Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med 376:2032–2042

    Article  CAS  PubMed  Google Scholar 

  3. Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J, Miguet B, Guinet P et al (2017) Effect of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass: the LICORN randomized clinical trial. JAMA 318:548–556

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Harrison RW, Hasselblad V, Mehta RH, Levin R, Harrington RA, Alexander JH (2013) Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 27:1224–1232

    Article  CAS  PubMed  Google Scholar 

  5. Putzu A, Clivio S, Belletti A, Cassina T (2018) Perioperative levosimendan in cardiac surgery: a systematic review with meta-analysis and trial sequential analysis. Int J Cardiol 251:22–31

    Article  PubMed  Google Scholar 

  6. Sanfilippo F, Knight JB, Scolletta S, Santonocito C, Pastore F, Lorini FL, Tritapepe L, Morelli A et al (2017) Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis. Crit Care 21:252

    Article  PubMed  PubMed Central  Google Scholar 

  7. Treskatsch S, Balzer F, Geyer T, Spies CD, Kastrup M, Grubitzsch H, Wernecke KD, Erb JM et al (2015) Early levosimendan administration is associated with decreased mortality after cardiac surgery. J Crit Care 30(859):e851–e856

    Google Scholar 

  8. Tritapepe L, De Santis V, Vitale D, Guarracino F, Pellegrini F, Pietropaoli P, Singer M (2009) Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 102:198–204

    Article  CAS  PubMed  Google Scholar 

  9. Theiss HD, Grabmaier U, Kreissl N, Hagl C, Steinbeck G, Sodian R, Franz WM, Kaczmarek I (2014) Preconditioning with levosimendan before implantation of left ventricular assist devices. Artif Organs 38:231–234

    Article  CAS  PubMed  Google Scholar 

  10. Kocabeyoglu SS, Kervan U, Sert DE, Karahan M, Aygun E, Beyazal OF, Unal EU, Akin Y et al (2020) Optimization with levosimendan improves outcomes after left ventricular assist device implantation. Eur J Cardiothorac Surg 57:176–182

    Article  PubMed  Google Scholar 

  11. Sugimura Y, Kalampokas N, Arikan M, Rellecke P, Dalyanoglu H, Tudorache I, Westenfeld R, Boeken U et al (2023) Preoperative Levosimendan therapy reduces postoperative right ventricular failure in patients undergoing left ventricular assist device implantation. Interdiscip Cardiovasc Thorac Surg 1:ivac289

  12. Guarracino F, Heringlake M, Cholley B, Bettex D, Bouchez S, Lomivorotov VV, Rajek A, Kivikko M et al (2018) Use of levosimendan in cardiac surgery: an update after the LEVO-CTS, CHEETAH, and LICORN trials in the light of clinical practice. J Cardiovasc Pharmacol 71:1–9

    Article  CAS  PubMed  Google Scholar 

  13. Greco T, Calabro MG, Covello RD, Greco M, Pasin L, Morelli A, Landoni G, Zangrillo A (2015) A Bayesian network meta-analysis on the effect of inodilatory agents on mortality. Br J Anaesth 114:746–756

    Article  CAS  PubMed  Google Scholar 

  14. Habicher M, Zajonz T, Heringlake M, Boning A, Treskatsch S, Schirmer U, Markewitz A, Sander M (2018) S3 guidelines on intensive medical care of cardiac surgery patients : Hemodynamic monitoring and cardiovascular system—an update. Anaesthesist 67:375–379

    Article  CAS  PubMed  Google Scholar 

  15. Caruba T, Charles-Nelson A, Alexander JH, Mehta RH, Heringlake M, Toller W, Yavchitz A, Sabatier B et al (2022) Prophylactic levosimendan in patients with low ejection fraction undergoing coronary artery bypass grafting: a pooled analysis of two multicentre randomised controlled trials. Anaesth Crit Care Pain Med 41:101107

    Article  PubMed  Google Scholar 

  16. Van Diepen S, Mehta RH, Leimberger JD, Goodman SG, Fremes S, Jankowich R, Heringlake M, Anstrom KJ et al (2020) Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. J Thorac Cardiovasc Surg 159:2302–2309 (e2306)

    Article  PubMed  Google Scholar 

  17. Wang W, Zhou X, Liao X, Liu B, Yu H (2019) The efficacy and safety of prophylactic use of levosimendan on patients undergoing coronary artery bypass graft: a systematic review and meta-analysis. J Anesth 33:543–550

    Article  PubMed  Google Scholar 

  18. Woehrle T, Mehringer L, Juchem G, Dashkevich A, Weis M, Schunemann M, Kilger E (2021) Individualized use of levosimendan in cardiac surgery. Anaesthesist 70:204–212

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tobias Wöhrle DESA.

Ethics declarations

Interessenkonflikt

T. Wöhrle und E. Kilger geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Hinweis des Verlags

Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.

Den dazugehörigen Artikel Contra: Levosimendan bei herzchirurgischen Eingriffen von Valerie Heinz und Gunther Wiesner finden Sie unter dem https://doi.org/10.1007/s00101-023-01361-6.

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wöhrle, T., Kilger, E. Pro: Levosimendan bei herzchirurgischen Eingriffen. Anaesthesiologie 73, 60–61 (2024). https://doi.org/10.1007/s00101-023-01360-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-023-01360-7

Navigation